Research | OneLook Acronym Finder |
Serial Number | 87682406 |
Registration Number | 5870823 |
Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
Attorney Name | John Pickerill |
Attorney Docket Number | 76724 |
Law Office Assigned | L30 |
Employee Name | DYER, ERIN ZASKODA |
2017-11-13 | Application Filed |
2019-07-16 | Published for Opposition |
2019-10-01 | Location: PUBLICATION AND ISSUE SECTION |
2019-10-01 | Status: Live/Registered |
2019-10-01 | Trademark Registered |
2019-10-01 | Transaction Date |
Owner: | Cosmo Technologies Ltd |
Entity Statement | limited company (ltd.) |
Address | Riverside II Sir John Rogerson's Quay Dublin 2 IE 0 |
Legal Entity Type | |
Legal Entity State | IE |
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
International Codes: | 5 |
U.S. Codes: | 006,018,044,046,051,052 |
Type Code | Type |
---|---|
GS0051 | Diagnostic agents, preparations and substances for medical and surgical purposes; Diagnostic agents, preparations and substances for medical purposes, namely, the enhancing of adenomatous, cancerous and other proliferative lesions in the colon for patients undergoing colonoscopy and for the visualization of colonic adenoma in patients undergoing screening colonoscopy including patients at high risk of colorectal carcinoma (CRC), including those with previous history of polyps at prior colonoscopy, patients with colorectal cancer and patients with family history; Diagnostic reagents and contrast media for medical and surgical use; Contrast media for use with imaging medical equipment; Contrast media for use with colonoscopic equipment; pharmaceutical preparations for use in gastroenterology; pharmaceutical preparations for use in colonoscopy; pharmaceutical preparations for the differentiation of the tissues of the intestines and colon and lesions thereto; pharmaceutical preparations for use in the colonoscopic diagnostic evaluation; methylene blue for pharmaceutical, medical, surgical and medical diagnostic purposes; dye for pharmaceutical, medical, surgical and medical diagnostic purposes; pharmaceutical preparations for use in the endoscopic diagnostic evaluation; pharmaceutical compositions for use in endoscopy; methylene blue for pharmaceutical, medical, surgical and medical diagnostic purposes, namely, for enhancing visualization during colonoscopy; dyes for pharmaceutical, medical, surgical and medical diagnostic purposes, namely, for enhancing visualization during colonoscopy |
GS0051 | Diagnostic agents, preparations and substances for medical and surgical purposes; Diagnostic agents, preparations and substances for medical purposes, namely, the enhancing of adenomatous, cancerous and other proliferative lesions in the colon for patients undergoing colonoscopy and for the visualization of colonic adenoma in patients undergoing screening colonoscopy including patients at high risk of colorectal carcinoma (CRC), including those with previous history of polyps at prior colonoscopy, patients with colorectal cancer and patients with family history; Diagnostic reagents and contrast media for medical and surgical use; Contrast media for use with imaging medical equipment; Contrast media for use with colonoscopic equipment; pharmaceutical preparations for use in gastroenterology; pharmaceutical preparations for use in colonoscopy; pharmaceutical preparations for the differentiation of the tissues of the intestines and colon and lesions thereto; pharmaceutical preparations for use in the colonoscopic diagnostic evaluation; methylene blue for pharmaceutical, medical, surgical and medical diagnostic purposes; dye for pharmaceutical, medical, surgical and medical diagnostic purposes; pharmaceutical preparations for use in the endoscopic diagnostic evaluation; pharmaceutical compositions for use in endoscopy; methylene blue for pharmaceutical, medical, surgical and medical diagnostic purposes, namely, for enhancing visualization during colonoscopy; dyes for pharmaceutical, medical, surgical and medical diagnostic purposes, namely, for enhancing visualization during colonoscopy |
Description | Date | Event Coding |
---|---|---|
NEW APPLICATION ENTERED IN TRAM | 2017-11-16 | 1 NWAP I:Incoming Correspondence |
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2017-11-24 | 2 NWOS I:Incoming Correspondence |
ASSIGNED TO EXAMINER | 2017-12-07 | 3 DOCK D:Assigned to Examiner |
NON-FINAL ACTION WRITTEN | 2017-12-07 | 4 CNRT R:Renewal |
NON-FINAL ACTION E-MAILED | 2017-12-07 | 5 GNRT F:First Action |
NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2017-12-07 | 6 GNRN O:Outgoing Correspondence |
TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2018-06-07 | 7 TROA I:Incoming Correspondence |
ASSIGNED TO LIE | 2018-06-21 | 8 ALIE A:Allowance for Publication |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2018-06-25 | 9 CRFA I:Incoming Correspondence |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2018-06-25 | 10 TEME I:Incoming Correspondence |
SUSPENSION LETTER WRITTEN | 2018-07-21 | 11 CNSL R:Renewal |
LETTER OF SUSPENSION E-MAILED | 2018-07-21 | 12 GNSL S: |
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | 2018-07-21 | 13 GNS3 O:Outgoing Correspondence |
LIE CHECKED SUSP - TO ATTY FOR ACTION | 2019-02-04 | 14 RCCK S: |
SUSPENSION INQUIRY WRITTEN | 2019-02-25 | 15 CNSI R:Renewal |
INQUIRY TO SUSPENSION E-MAILED | 2019-02-25 | 16 GNSI S: |
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | 2019-02-25 | 17 GNS2 O:Outgoing Correspondence |
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | 2019-05-28 | 18 ERSI I:Incoming Correspondence |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2019-05-30 | 19 CRFA I:Incoming Correspondence |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2019-05-30 | 20 TEME I:Incoming Correspondence |
TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2019-05-28 | 21 TCCA I:Incoming Correspondence |
APPROVED FOR PUB - PRINCIPAL REGISTER | 2019-06-13 | 22 CNSA O:Outgoing Correspondence |
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2019-06-26 | 23 NONP E:E-Mail |
PUBLISHED FOR OPPOSITION | 2019-07-16 | 24 PUBO A:Allowance for Publication |
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2019-07-16 | 25 NPUB E:E-Mail |
REGISTERED-PRINCIPAL REGISTER | 2019-10-01 | 26 R.PR A:Allowance for Publication |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.